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aspase-directed apoptosis usually fragments cells, re-
leasing nonfunctional, prothrombogenic, membrane-
bound apoptotic bodies marked for rapid engulfment
by macrophages. Blood platelets are functional anucleate
cells generated by specialized fragmentation of their
progenitors, megakaryocytes (MKs), but committed to a
constitutive caspase-independent death. Constitutive form-
ation of the proplatelet-bearing MK was recently reported
to be caspase-dependent, apparently involving mitochondrial
release of cytochrome 
 
c
 
, a known pro-apoptogenic factor.
We extend those studies and report that activation of
C
 
caspases in MKs, either constitutively or after Fas ligation,
yields platelets that are functionally responsive and evade
immediate phagocytic clearance, and retain mitochondrial
transmembrane potential until constitutive platelet death
ensues. Furthermore, the exclusion from the platelet progeny
of caspase-9 present in the progenitor accounts for failure
 
of mitochondrial release of cytochrome 
 
c
 
 to activate caspase-3
during platelet death. Thus, progenitor cell death by
apoptosis can result in birth of multiple functional anucleate
daughter cells.
 
Introduction
 
Blood platelets are anucleate cells vital for hemostasis,
generated within bone marrow by a highly specialized form
of progenitor cell fragmentation (Tavassoli and Aoki,
1989). Platelet progenitors, the megakaryocytes (MKs),*
undergo a dramatic morphological change in which the
MK extends long bifurcating filamentous projections.
These “proplatelet”-bearing MKs then develop platelet-
sized nodes through the specific delivery of platelet material
along the processes, which appear similar to beads on a
string. Mature platelets are then released in large numbers
from the tip of such processes (Stenberg and Levin, 1989;
Cramer et al., 1997; Italiano et al., 1999). This process is
markedly different from the blebbing or zeiosis of cells dying
by apoptosis, in which membrane-bound bodies bud indi-
vidually from the cell surface (Kerr et al., 1972; Robertson
et al., 1978). Cultured MK cells have also been observed to
undergo apoptosis in vitro (Zauli et al., 1997), and rem-
nant MK cell bodies containing nuclei with typical apop-
totic chromatin condensation are evident in bone marrow
in vivo (Radley and Haller, 1983). Furthermore, studies
have recently revealed that pro-apoptotic stimuli such as
nitric oxide can, in concert with potentially pro-apoptotic
 
cytokines such as TNF-
 
 
 
 and IFN-
 
 
 
, trigger increased re-
lease of platelet-like bodies from cultured MK cells (Batti-
nelli et al., 2001). More recently, evidence was provided
that proplatelet formation in response to thrombopoietin
(TPO) was a consequence of caspase activation dependent
on mitochondrial release of the pro-apoptogenic factor
cytochrome 
 
c
 
, indicative of an intrinsic program of cell
death (De Botton et al., 2002). However, no data has yet
demonstrated that such specialized MK cell death gives rise
to mature functional progeny.
For some time, we have been interested in the relation-
ship between MK apoptosis and platelet production. In
particular, we were intrigued by the possible role of cas-
pases in both processes, as we had previously shown that
mature blood platelets were committed to a caspase-indepen-
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PRP, platelet-rich plasma; PS, phosphatidylserine; TEM, transmission
electron microscopy; TPO, thrombopoietin.
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dent program of cell death (Brown et al., 2000). Thus, when
deprived of plasma as a source of survival factors, cultured
platelets exhibited morphological condensation accompa-
nied by exposure of phosphatidylserine (PS), maintenance of
plasma membrane integrity, and specific recognition and en-
gulfment by monocyte-derived macrophages (MDMs) using
the class-A scavenger receptor (Brown et al., 2000). Al-
though these events were strongly reminiscent of constitu-
tive apoptosis in cultured leukocytes, a key difference was
that platelet death was not inhibited by broad-spectrum cas-
pase inhibitors, nor was there evidence of activation by
cleavage of effector caspase-3 (Brown et al., 2000), which is
found in abundance in platelets.
The current study supports the hypothesis that MKs
produce platelets by a novel compartmentalized form of cas-
pase-directed apoptosis (De Botton et al., 2002), but impor-
tantly extends those studies to show that such proplatelet
MKs yield functional platelets that retain inner mitochon-
drial membrane potential (
 
  
 
M) and membrane PS asym-
metry. By contrast, the MK cell body exhibited typical nu-
clear morphological features of apoptosis. Further evidence
of compartmentalized progenitor cell death was the absence
from viable platelets of caspase-9 present in MKs, account-
ing for the caspase-independent nature of constitutive plate-
let death.
 
Results
 
Constitutive apoptosis in MKs is associated with 
production of functional platelets
 
Production of platelets from their progenitors, MKs, occurs
through an intermediate proplatelet phenotype consisting of
thin cytoplasmic processes along which platelet-sized nodes
develop before platelets are released by multiple detachment
events from the process tip (Stenberg and Levin, 1989;
Cramer et al., 1997; Italiano et al., 1999). Using cultures of
the well validated MEG-01 human MK cell line (Ogura et
al., 1985), which spontaneously produces functional plate-
lets under normal culture conditions (Takeuchi et al.,
1998), we observed proplatelet MKs at a frequency of 0.6 
 
 
 
0.1% (Table I). Intriguingly, both proplatelet MK fre-
quency and production of functional platelets were signifi-
cantly reduced by the broad-spectrum caspase inhibitor
zVAD-fmk (Table I), implying a role for caspase-directed
apoptosis in the formation of proplatelet extensions by MKs
and the subsequent production of functional platelets. Fur-
thermore, in studies focusing on the important initial event
in platelet production, formation of proplatelet extensions
by MKs, we also observed inhibition by zVAD-fmk and by
the more specific peptide inhibitor of caspase-3, zDEVD-
fmk, at only 10 
 
 
 
M (Table II). To confirm this inhibitor ev-
Figure 1. Proplatelet-extending MKs 
exhibit nuclear pyknosis and contain 
active caspases. (a) A mature MEG-01 
MK displaying proplatelet extensions, 
stained positive for active caspases with 
CaspaTag™ (green), which remained 
localized within the main cell body. 
Note that MKs without proplatelet 
extensions (left and right) lacked caspase 
activity. (b) Dual staining of nuclear 
material with Hoechst 33342 (blue) and 
active caspases reveals MKs bearing 
proplatelets to contain pyknotic nuclei, 
with nuclear material remaining within 
the cell body along with active caspases. 
Bars, 20  m.
 
Table I. 
 
Fas ligation augments platelet production by MKs in a zVAD-fmk–inhibitable manner
Condition 
Proplatelet MKs 
per 2 
 
 
 
 10
 
5
 
 MKs
Functional platelet yield 
 
 
 
 10
 
4
 
 
per 2 
 
 
 
 10
 
5
 
 MKs
 
Control 1,193 
 
 
 
 183  26 
 
 
 
 3
ZVAD-fmk (100 
 
 
 
M)  5 
 
 
 
 8
 
a
 
13 
 
 
 
 1
 
a
 
CH11 (50 ng/ml) 8,024 
 
 
 
 1,777
 
a
 
234 
 
 
 
 38
 
a
 
CH11;ZB4 (50 ng/ml;
 
 
 
1 
 
 
 
g/ml)  ND  31 
 
 
 
 2
CH11;zVAD-fmk (50 ng/ml; 100 
 
 
 
M)  784 
 
 
 
 115
 
a
 
 28 
 
 
 
 4
sFas-L (5 ng/ml)  ND 134 
 
 
 
 28
 
a
 
sFas-L;zVAD-fmk (5 ng/ml; 100 
 
 
 
M)  ND 29 
 
 
 
 9
TNF
 
 
 
 (25 ng/ml)   ND 30 
 
 
 
 5
Proplatelet MK count represents total number of proplatelet-bearing MKs following 8 h of culture, scored by phase microscopy. Functional platelet yield
represents total number of platelets produced following 18 h of culture, enumerated as detailed in Fig. 3. CH11 is an anti-Fas agonistic mAb, and ZB4 an
antagonistic mAb. Data represent mean 
 
 
 
 SD of a minimum of three determinations. 
 
a
 
P 
 
 
 
 0.01 compared to control.T
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idence of caspase activation driving platelet production, we
used a quenched fluorescent reagent of broad specificity for
caspases, CaspaTag™, finding that the cell body of pro-
platelet-bearing MKs contained active caspases, whereas the
processes did not (Fig. 1 A). Similar results were obtained
with SET-2, another MK cell line (unpublished data).
Because our own data confirmed the report by De Botton
et al. (2002) that caspase activation was important in forma-
tion of proplatelet MKs, we went on to seek the morpholog-
ical hallmarks of apoptosis in MKs extending proplatelet ex-
tensions. The main cell body of proplatelet MKs failed to
exclude the vital dye Hoechst 33342, revealing chromo-
somal condensation and nuclear fragmentation typical of ap-
optosis (Fig. 1 B). Indeed, transmission electron microscopy
(TEM) revealed that MKs undergoing the very earliest stages
of cytoplasmic projection exhibited clear heterochromatin
condensation typical of early apoptosis (Kerr et al., 1972),
proceeding to extensive condensation in those bearing pro-
platelet extensions (Fig. 2). These data demonstrated that
caspase-mediated MK apoptosis was responsible for the pro-
duction of mature platelets, and were further supported by
constitutive internucleosomal chromatin cleavage (DNA
laddering) typical of apoptosis in MKs cultured under con-
trol conditions (Wyllie, 1980; unpublished data).
The anucleate cells produced by MEG-01 MKs were mor-
phologically indistinguishable from blood platelets; TEM
revealing a discoid shape and a characteristic distribution of
 
 
 
 and dense granules (Fig. 2 F). Flow cytometry further re-
vealed that MK-derived platelets, identified by positive
staining for GpIIb/IIIa (unpublished data), did not bind an-
nexin-V (a marker of PS exposure), excluded propidium io-
dide, were able to undergo the key functional response of
shape change (Otterdal et al., 2001) (Fig. 3), and displayed a
characteristic transient calcium flux, detected with Fluo3
(unpublished data), when stimulated by either thrombin or
ADP. By contrast, MK fragments bound annexin-V and
 
Table II. 
 
Caspases direct constitutive and Fas-induced proplatelet formation
 Proplatelet MKs per 2 
 
 
 
 10
 
5
 
 MKs
Condition  Constitutive  CH11 induced
 
Control 1,340 
 
 
 
 147 7,930 
 
 
 
 923
zVAD-fmk (10 
 
 
 
M) 82 
 
 
 
 36
 
a
 
 245 
 
 
 
 47
 
a
 
zDEVD-fmk (10 
 
 
 
M) 227 
 
 
 
 55
 
a
 
 990 
 
 
 
 247
 
a
 
zIETD-fmk (10 
 
 
 
M) 699 
 
 
 
 97
 
a
 
 536 
 
 
 
 103
 
a
 
BioPORTER
 
®
 
 control   1,516 
 
 
 
 48 4,756 
 
 
 
 372
BioPORTER
 
®
 
 crmA 1,387 
 
 
 
 156 2,396 
 
 
 
 240
 
b
 
BioPORTER
 
®
 
 HI crmA  ND 4,400 
 
 
 
 500
BioPORTER
 
®
 
 active caspase-8 2,502 
 
 
 
 368
 
b
 
ND
Proplatelet MK count represents total number of proplatelet-bearing MKs following 8 h of culture, scored by phase microscopy. zDEVD-fmk has enhanced
specificity over zVAD-fmk as a caspase-3 inhibitor. HI, heat inactivated; Data represent mean 
 
 
 
 SD of a minimum of three determinations.
 
a
 
P 
 
 
 
 0.01 compared to control.
 
b
 
P 
 
 
 
 0.01 compared to BioPORTER
 
®
 
 control.
 
Figure 2.
 
Mature MKs exhibit nuclear condensation typical of 
apoptosis, producing bodies indistinguishable from blood platelets.
 
 
Purified mature MEG-01 MKs where examined by TEM. (a) MKs, 
shown at higher magnification in b to demonstrate a typical distribution 
of 
 
 
 
-granules and demarcation membranes (arrows), contain nuclei 
with evenly dispersed heterochromatin. (c) MK, shown at higher 
magnification in d, exhibiting early cytoplasmic rearrangements 
consistent with platelet formation (arrows), with a nucleus displaying 
heterochromatin condensation typical of early apoptosis. (e) MK-
bearing proplatelets show extensive condensation and fragmen-
tation of the nuclear material (arrow). (f) TEM of MEG-01 MK 
culture supernatants reveals platelets with morphology consistent 
with that typically observed for blood platelets. Bars: 20 
 
 
 
m (a–e) 
and 1 
 
 
 
m (f).T
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propidium iodide and did not undergo agonist-induced
shape change (Fig. 3). Furthermore, the functional nature of
MK-derived platelets was emphasized by the thrombin-stim-
ulated conformational change of GpIIb/IIIa to a fibrinogen-
binding competent state, as assessed by flow cytometry using
labeled fibrinogen (t 
 
 
 
 20 s 
 
 
 
 21.6%; t 
 
 
 
 40 s 
 
 
 
 40.1%).
 
Fas ligation augments platelet production by MKs
 
In view of this and other evidence (De Botton et al., 2002)
that constitutive caspase-mediated apoptosis of proplatelet
MKs was associated with platelet production, we hypothe-
sized that the classical pro-apoptotic stimulus of Fas ligation
might be sufficient to increase platelet production. Ligation
of MK Fas by either agonistic anti-Fas antibody (CH.11) or
soluble Fas ligand over an 18-h period resulted in a signifi-
cant increase in proplatelet extensions and production of vi-
able (annexin-V–negative) platelets, shown to be functional
as detailed above (Fig. 3). This increase in proplatelet forma-
tion and functional platelet production was shown to be
caspase-dependent by the inhibitory effects of zVAD-fmk
and zIETD-fmk (Tables I and II). However, ligation of the
TNF-
 
 
 
 death receptor with TNF-
 
 
 
 did not increase platelet
production (Table I). Furthermore, an essential role for Fas-
directed activation of initiator caspases in driving MK pro-
platelet extension was provided by direct protein transduc-
tion of the protein CrmA (Table II), a potent inhibitor of
such initiator caspases (Garcia-Calvo et al., 1998). Impor-
tantly, CrmA had no effect on constitutive formation of pro-
platelet MKs. Indeed, introduction of active caspase-8,
which is directly activated by Fas ligation, specifically in-
creased proplatelet extension (Table II). Epifluorescent mi-
croscopy of Fas-stimulated MK cultures further revealed
Figure 3. Culture-derived platelets are 
functional. (a) Freshly isolated blood 
platelets undergo an agonist-induced 
shape change in response to thrombin 
(as indicated), detected as an increase in 
side scatter with events moving from 
gate R1 to R2. Absolute counts of plate-
lets were obtained by spiking samples 
with a fixed number of 10- M beads 
(R3). (b) Freshly isolated blood platelets 
treated with or without agonist (as indi-
cated) rarely bound annexin-V under the 
conditions used. (c) In contrast, culture-
derived platelets contained an annexin-
V–positive population, with only an-
nexin-V–negative cells undergoing 
thrombin-induced shape change. (d) 
Culture-derived platelets incubated with 
MDMs result in clearance of debris 
with the remaining population able to 
shape change on stimulation. Functional 
platelets were defined as being annexin-
V–negative and capable of undergoing 
shape change in response to agonist.T
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that 95 
 
 
 
 3% (mean 
 
 
 
 SD of 
 
n
 
 
 
 
 
 3) of the proplatelet-
bearing cells exhibited nuclear condensation typical of apop-
tosis, and that 89 
 
 
 
 3% (mean 
 
 
 
 SD of 
 
n
 
 
 
 
 
 3) exhibited
staining for active caspases within the main cell body. These
observations were reproduced with primary murine MKs
differentiated from bone marrow. Using Jo-2, an anti-
murine Fas agonistic mAb, we again observed that the num-
ber of functional platelets produced increased in a caspase-
dependent manner after 18 h of treatment (Fig. 4 A).
Furthermore, identical results were obtained using a
novel human bone core explant bio-culture system (Smith
and Jones, 1998). Human trabecular bone from femoral
heads, removed at surgery, contained viable bone marrow
and constitutively produced platelets after 4 d that stained
positive for the lineage specific fibrinogen receptor (GpIIb/
IIIa). Such platelet production was robustly inhibited by
zVAD-fmk and augmented in a zVAD-fmk inhibitable
manner by Fas ligation (Fig. 4 B). Importantly, and al-
though the relatively small number of platelet-like particles
generated in this system precluded any functional assess-
ment, ultrastructural analysis by TEM again showed mor-
phology consistent with blood platelets (Brown et al., 2000;
Fig. 4, C and D).
 
Platelets generated by MK apoptosis are not ingested 
by macrophages
 
To confirm the morphological and functional evidence that
platelets produced by MEG-01 MKs undergoing apoptosis
were viable, we investigated whether MDMs would selec-
tively clear nonfunctional platelets and MK fragments. Incu-
bating MK culture supernatants with MDMs resulted in the
selective clearance of all PS-positive bodies, leaving a popula-
tion of functional platelets demonstrating agonist-induced
shape change (Fig. 3 D).
 
Mitochondrial permeability transition is not observed 
in proplatelet MK extensions and occurs only as 
mature platelets die
 
The foregoing data strongly implied that a compartmental-
ized form of apoptosis in proplatelet MKs gave rise to viable
platelets and an apoptotic remnant body. Because mito-
chondrial permeability transition is a prominent feature of
caspase-mediated apoptosis, we investigated proplatelet MK
 
  M using JC-1, a mitochondrial dye that fluoresces orange
in respiring mitochondria that maintain   M (Petit et al.,
1995; Salvioli et al., 1997). Importantly, we found that mi-
tochondria, localized to platelet-sized nodes along the cyto-
plasmic extensions of proplatelet MKs, had not undergone
permeability transition despite double staining with Hoechst
33342 showing clear morphological evidence of nuclear
condensation and fragmentation within the main cell body
(Fig. 5, A and B). In addition, confocal microscopy revealed
that mitochondria remaining within the cell body were po-
larized to the MK edge with the remaining proplatelet
“bridge” still attached (Fig. 5 C). Furthermore, viable MK
culture-derived platelets that were allowed to adhere and
spread on glass also showed no evidence of mitochondrial
permeability transition (Fig. 5 D). This was only observed
when mature human blood platelets were cultured in the ab-
Figure 4. Caspase-dependent production of platelets by primary 
murine MKs and human bone cores is augmented by Fas ligation. 
(a) Mature primary murine MKs produce functional platelets, 
inhibitable with zVAD-fmk and augmented with the anti-murine 
Fas ligating antibody JO-2. Functional platelets were enumerated as 
for Fig. 3. Data represent mean   SD, n   4. ** denotes P   0.02. 
(b) Ex vivo human bone core explants, maintained within a Zetos™ 
bone perfusion chamber, were exposed to fresh media containing 
CH.11 and/or zVAD-fmk as indicated. Perfused media was collected 
over 18 h and GpIIb/IIIa platelets were enumerated by flow cytometry. 
Data represent mean   SD. ** denotes P   0.05. (c) TEM of perfused 
media components showing presence of platelets with morphology 
consistent with blood-derived platelets (d). Bars in c and d , 1  m.T
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sence of plasma-derived survival factors for 16 h to allow
constitutive death (Brown et al., 2000), or when fresh blood
platelets were treated with the respiratory chain uncoupler
mCCCP (Fig. 6 A).
  M collapse and the opening of the permeability transi-
tion pore is associated with mitochondrial release of cyto-
chrome c, a prerequisite for the formation of cytoplasmic ap-
optosome complexes (Liu et al., 1996; Marchetti et al.,
1996; Kluck et al., 1997; Li et al., 1997; Yang et al., 1997),
normally comprising coaggregated APAF-1, caspase-9, cyto-
chrome  c, and dATP. In keeping with this sequence of
events, we found cytochrome c to be contained within the
mitochondrial-enriched pellet of viable platelets, but to have
been released into the cytosolic fraction of senescent platelets
or apoptotic Jurkat cells, used as a control (Fig. 6 B).
Unlike MKs, freshly isolated platelets lack caspase-9, 
which is required for caspase-3 activation 
in platelet lysates
We were intrigued by mitochondrial permeability transition
and cytochrome c release in senescent platelets because our
previous work had clearly shown that constitutive death in
such platelets was caspase-independent, with no evidence of
the caspase-3 activation normally seen in caspase-mediated
apoptosis (Brown et al., 2000). Together, these data implied
that freshly isolated mature blood platelets lacked either
APAF-1 or caspase-9, key components of the apoptosome
that cleaves caspase-3 to its active p12/17 form (Liu et al.,
1996; Li et al., 1997).
Two lines of evidence demonstrated that platelets (but not
MKs) lacked caspase-9. First, Western blot analysis of blood
platelets confirmed that APAF-1 was present and at compa-
rable levels to Jurkat T cells (Fig. 7 A). However, although
caspase-9 was readily identified in Jurkat T cells, migrating
with an apparent molecular size of 48 kD, caspase-9 could
not be detected in blood platelets. Importantly, the MK cell
lines MEG-01 and SET-2 expressed caspase-9, and at levels
equivalent to Jurkat T cells using both a polyclonal (Fig. 7
B) and a monoclonal antibody (unpublished data), indicat-
ing exclusion of the enzyme during platelet formation.
Second, we attempted to activate caspase-9 in fresh plate-
let lysates by adding exogenous cytochrome c and dATP,
which should have reconstituted an active apoptosome
complex capable of processing caspase-3 to its active p12/
Figure 5. Functional platelet production is 
associated with the maintenance of   M. 
(a and b) Mature MEG-01 MKs were double 
stained with the   M-sensitive dye JC-1
(orange), and the nuclear staining vital dye 
Hoechst 33342 (blue). Mitochondria with 
an intact   M are seen localized within 
platelet-sized nodes along extended pro-
platelets, whereas the cell bodies display 
nuclear condensation. (c) An MK stained 
with JC-1 only and analyzed by confocal 
microscopy reveals functional mitochondria 
with an intact   M to be polarized within 
the cell body toward the remaining attached 
proplatelet (arrow). Bars in a–c, 20  m. 
(d) Culture-derived platelets were also 
stained with JC-1 and allowed to adhere 
and spread on glass. Again, mitochondria 
with an intact   M are seen coalesced 
within the body of the spreading platelet. 
Bar in d, 5  m.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 Compartmentalized cell death and platelet formation | Clarke et al. 583
17 form (Liu et al., 1996; Li et al., 1997). However, pro-
caspase-3 remained unprocessed (Fig. 8 A), whether con-
trol platelet lysates or those treated with exogenous cyto-
chrome c/dATP were examined. This was in stark contrast
to caspase-3 activation by Jurkat T cell lysates where expo-
sure to cytochrome c/dATP revealed a progressive process-
ing of procaspase-3 to the p12/17 active fragment (Fig. 8
B). Similar processing was obtained using lysates from
MEG-01 MKs (unpublished data). As the only proteins re-
quired for cell-free caspase-3 processing are caspase-9 and
APAF-1, we examined whether addition of recombinant
caspase-9 could reconstitute caspase-3 cleavage in lysates
from fresh platelets. Using the same preparations of fresh
platelet lysates as above, we observed that the addition of
hrCaspase-9 (0.1 U/ml) resulted in the processing of cas-
pase-3, presumably by reconstitution and activation of the
apoptosome complex (Fig. 8 C). Therefore, two lines of ev-
idence indicate that a further manifestation of the apparent
compartmentalization of apoptosis in proplatelet MKs is
exclusion of caspase-9 from the platelet progeny, commit-
ting them to a caspase-independent program of constitutive
cell death.
Discussion
Our key conclusion, in agreement with that of De Botton et
al. (2002), is that compartmentalized apoptosis of a progeni-
tor cell is a hitherto unrecognized mechanism for generation
of multiple, functional anucleate daughter cells. Thus, pro-
platelet MKs exhibited clear morphological evidence of nu-
clear changes of apoptosis and caspase activation in the main
cell body, but bore processes that retained   M and yielded
functional anucleate progeny (platelets) that very impor-
tantly were not marked for immediate clearance by MDMs.
Strong mechanistic evidence also supported caspase-directed
MK apoptosis as critical to both formation of proplatelet
MKs and production of functional platelets. First, both pa-
rameters were inhibited in constitutive MK cultures by
caspase inhibition with the poly-caspase inhibitor zVAD-
fmk, with caspase-3 implicated by use of a well-established
peptide inhibitor zDEVD-fmk. Second, platelet production
could be driven in the human MEG-01 MK cell line, pri-
mary murine MKs and a novel human bone marrow tissue
culture system by the classical pro-apoptotic stimulus of Fas
ligation, which induced proplatelet MKs exhibiting nuclear
Figure 6. Senescent platelets show loss of   M 
and release of mitochondrial cytochrome c. 
(a) Fresh PRP, aged PRP, or aged washed platelets, 
as indicated, were stained with the   M-sensitive 
dye JC-1. (i) Flow cytometric analysis of fresh 
platelets display a typical fluorescent profile of 
high orange fluorescence, indicative of an intact 
  M. (ii) Platelets aged in the presence of plasma 
survival factors show a small ( 10%) distinct sub-
population characteristic of a collapsed   M, i.e., 
loss of FL2-H fluorescence with concomitant 
increase in FL1-H. (iii) By contrast, aged washed 
platelets display  100% loss of   M. (iv) Treat-
ment of fresh platelets with the protonophore 
mCCCP resulted in a collapse of the   M, equivalent 
to that seen with aged platelets. (b) Aged platelets 
release mitochondrial cytochrome c into the cyto-
plasm. Fresh (viable) and aged washed (nonviable) 
platelets, as indicated, were lysed and cells were 
fractionated by centrifugation to yield a cytosolic 
supernatant and a subcellular pellet. Both supernatant 
and solubilized pellet were precleared with a control 
IgG before immunoprecipitating cytochrome c. 
Cytochrome c was detected by Western blot analysis, 
in which Jurkats treated with cycloheximide are 
provided as a positive control.T
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condensation of apoptosis. Third, Fas-directed proplatelet
MK formation was specifically inhibited by the use of the
potent inhibitor of initiator caspases, CrmA, and pointed to
the involvement of effector caspases in the formation of pro-
platelet MKs, mimicked by introduction of active caspase-8
into cultured MKs. However, the compartmentalized nature
of MK apoptosis leading to proplatelet and platelet produc-
tion was further emphasized by our finding that caspase-9, a
key component of the apoptosome after mitochondrial cyto-
chrome c release, was present in progenitor MKs but was ex-
cluded from platelets, accounting for the caspase-indepen-
dent nature of constitutive platelet death.
Our findings differ importantly from the probable role of
caspases in generation of the erythrocyte, another anucleate
cell (Zermati et al., 2001). Rather than production of multi-
ple daughter cells from a single progenitor (Stenberg and
Levin 1989; Cramer et al., 1997; Italiano et al., 1999), the
data suggest that viable erythrocytes transiently activate
caspases, resulting in cleavage of a subset of structural pro-
teins that may help lead to the enucleation of the erythro-
blast (Zermati et al., 2001) to produce a single erythrocyte
(Gregory and Eaves, 1978). Nevertheless, it seems clear that
evolution has achieved adaptations of the basic program of
cell death by apoptosis to produce anucleate cells of critical
importance in blood. However, such adaptations do not
yield immortal cells; viable platelets arising from compart-
mentalized MK death are committed to a short life span and
later death (Brown et al., 2000), in keeping with nucleated
blood cells such as neutrophils (Savill et al., 1989).
Our data also reinforce the concept that plasma mem-
brane changes of apoptosis may be dissociated from the
caspase-directed program of nuclear condensation and frag-
mentation (Knepper-Nicolai et al., 1998; Harper et al.,
2001). Clearly, further work will be required to define the
mechanisms by which caspase activation in one part of the
cell can lead to nuclear changes, whereas mitochondria in a
different area of the cell retain their   M, even when cell
death is induced by Fas ligation. Nevertheless, because it is
believed that there is specific delivery of progenitor cell cyto-
plasmic components into the extensions of proplatelet MKs
(Italiano et al., 1999), it is possible that there is specific ex-
clusion of death pathway components upstream of mito-
chondria analogous to the exclusion of caspase-9 suggested
by our data. Unfortunately, we could not directly test this
possibility because platelet yields from MK cultures were in-
sufficient for blotting studies, and the delicate nature of pro-
platelet-bearing MKs, which tended to lose their processes
Figure 7. Platelets contain APAF-1, but do not contain caspase-9. 
(a) Whole-cell lysates prepared from fresh platelets (i), Jurkat T cells 
(ii), and MEG-01 MKs (iii) were probed with an anti-APAF-1 pAb. 
All cells contained an immunodetectable protein with an apparent 
molecular mass of  130 kD, consistent with it being APAF-1. 
(b) Whole-cell lysates prepared from Jurkat T cells (i), fresh platelets 
(ii and iii), MEG-01 MKs (iv), and SET-2 MKs (v) were probed by 
Western blot for caspase-9 with a pAb that recognized both pro- 
and activated forms. A major band was detected with an apparent 
molecular mass approximating that of caspase-9 (48 kD) within 
Jurkat T cells and MKs. The Western blot was stripped and reprobed 
for  -actin, where  -actin accounts for 30% of platelet protein.
Figure 8. Exogenous cytochrome c/dATP fails 
to promote caspase-3 processing within platelet 
lysates. Cytosolic extracts were treated with cyto-
chrome c and dATP or buffer alone and incubated 
at 37 C. (a) Western blot analysis of platelet lysates 
revealed a failure of cytochrome c/dATP to pro-
mote the processing of caspase-3. (b) By contrast, 
Jurkat T cell lysates showed progressive processing 
of the enzyme to the proteolytically active p17/p12 
fragments. (c) On addition of human recombinant 
caspase-9 and cytochrome c/dATP to fresh platelet 
lysates, derived from the same preparation used 
above, caspase-3 was now processed to its active 
p17/p12 subunits. Each Western blot had 50  g of 
protein loaded per lane and was repeated twice.T
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on manipulation, excluded direct immunofluorescent local-
ization of caspase-9. However, despite our biochemical and
functional evidence that platelets lack caspase-9, others have
reported its presence (Wolf et al., 1999), even though our
data would suggest this should have resulted in caspase-3
cleavage, which we were unable to detect. Indeed, the possi-
bility that we might have artifactually “missed” caspase-9 ac-
tivity, because calcium-dependent calpains can indirectly
block caspase-3 activation by inactivating caspase-9 (Wolf et
al., 1999; Chua et al., 2000; Lankiewicz et al., 2000), ap-
peared most unlikely in our studies given the lack of Ca
2 ,
and presence of EGTA, EDTA, and calpain inhibitors
within the lysis buffer. Moreover, it should be noted that we
were particularly careful to ensure that our platelet prepara-
tions were free of low grade contamination by leukocytes,
which may have served as an artifactual source of caspase-9
(Webb et al., 2000; Bantel et al., 2001).
Future studies should also examine whether retention of
  M and plasma membrane asymmetry (denying recogni-
tion by phagocytes) in those parts of the dying MKs des-
tined to become platelets reflect special expression of anti-
apoptotic members of the Bcl-2 family. Such proteins have
been implicated in platelet production because knockout of
the pro-apoptotic Bcl-2–relative Bim results in reduced cir-
culating platelet counts, whereas other circulating blood cells
are increased (Bouillet et al., 1999), with identical effects be-
ing observed when the balance of Bcl-2 family members is
similarly shifted toward survival of hemopoietic cells by tar-
geted overexpression of Bcl-2 (Ogilvy et al., 1999). Al-
though such observations provide indirect support for MK
apoptosis being involved in platelet production, such data
require careful interpretation in the light of intriguing obser-
vations suggesting special patterns of antiapoptotic Bcl-XL
expression in MKs producing platelets (Sanz et al., 2001).
Thus, although Bcl-XL was greatly up-regulated (Terui et al.,
1998; Sanz et al., 2001) as MKs differentiated from CD34
 
progenitors and was detectable in proplatelet fragments and
mature platelets, potentially explaining the maintenance of
  M, Bcl-XL was apparently absent from senescent/apop-
totic MK cell bodies (Sanz et al., 2001). A further degree of
complexity is found with overexpression of Bcl-2 in CD34
 
progenitor cells cultured in vitro where proplatelet exten-
sions were inhibited (De Botton et al., 2002). This further
suggests that Bcl-2 members may be differentially targeted
to different populations of mitochondria, where Bcl-2 is
known to be absent from mature blood platelets (Brown et
al., 2000; Sanz et al., 2001). Such data may support sorting
of cytoplasmic proteins during formation of proplatelet ex-
tensions by MKs and emphasize the future need to over-
come technical and logistical problems to follow location of
Bcl-XL, caspase-9, and other relevant proteins in proplatelet
forming MKs in real time.
Nevertheless, our findings contrast with those of De Bot-
ton et al. (2002) in assigning relative importance to cyto-
chrome c and the intrinsic cell death program in the initia-
tion of proplatelet formation. Mitochondrial staining with
the   M-sensitive dye JC-1 suggested that during platelet
formation the mitochondria retained an active electron-
transport chain and were actively sorted to the proplatelets,
consistent with the high energy demands that are placed on
platelet formation (Watanabe et al., 1990) and the subse-
quent utilization of oxidative phosphorylation by platelets
throughout their life span (Doery et al., 1970; Akahori et al.,
1995; Parker and Gralnick, 1997). Given the intensity of
the JC-1 stain, we also failed to observe mitochondria with
altered fluorescence properties, indicative of a loss in   M
even when distinctive chromosomal margination of the at-
tached MK body was apparent. The ability of mitochondria
to resist participation in an apoptotic program that results in
proplatelet formation would also be assisted by the high lev-
els of reported Bcl-XL (Terui et al., 1998; Sanz et al., 2001),
thus able to inhibit an intrinsic (but not extrinsic) cell death
program. This is in keeping with further results where the
enforced release of cytochrome c by antagonism of anti-
apoptotic Bcl-XL with “BH3 mimetics” resulted in the loss
of   M and formation of platelet-like progeny that were
dysfunctional (unpublished data). Therefore, it is unlikely
that cytochrome c would be released into the cytosol of MKs
destined to extend processes and form functional platelets.
Furthermore, to our knowledge there is no precedent for the
long-term maintenance of   M after release of mitochon-
drial cytochrome c.
Our findings further support the idea that abnormalities
of circulating platelet numbers, important in disorders of he-
mostasis and in thrombotic diseases such as stroke and myo-
cardial infarction, could reflect abnormalities in control of
MK apoptosis. Indeed, in keeping with our findings, mice
deficient in components of the Fas death pathway exhibit
thrombocytopenia (Rieux-Laucat et al., 1995; Le Deist et
al., 1996), which has largely been attributed to autoimmune
thrombocytopenia. Indeed, one might speculate that phar-
macological manipulation of MK apoptosis, and the Fas
pathway in particular, might provide a novel therapeutic
strategy for the management and control of thrombostasis.
Materials and methods
All chemicals were of analytical reagent grade and purchased from Sigma-
Aldrich, and all culture media and supplements were obtained from
GIBCO BRL, unless stated otherwise.
Cell culture
The human megakaryoblastic cell line MEG-01 (Ogura et al., 1985; Euro-
pean Collection of Cell Cultures) and Jurkat T cells were routinely main-
tained in RPMI 1640 supplemented with 10% FCS, 2 mM L-glutamine, and
0.1 mg/ml penicillin/streptomycin. The human megakaryoblastic cell line
SET-2 (Uozumi et al., 2000; provided by K. Uozumi, Kagoshima Univer-
sity, Japan) was maintained in DME supplemented with 10% FCS, 2 mM
L-glutamine, 0.1 mg/ml penicillin/streptomycin, 10  M 2-mercaptoethanol,
and 10% nonessential amino acids. Generation of primary murine MKs is
described elsewhere (Drachman et al., 1997; Rojnuckarin and Kaushan-
sky, 2001). In brief, bone marrow was flushed from femurs of Balb-C mice
and a single cell suspension was obtained by gentle pipetting. Cells were
incubated overnight in StemSpan™ H2000 (StemCell Technologies, Inc.)
with 40 ng/ml
 human recombinant TPO (PeproTech), and all nonadherent
cells and media were transferred to fresh wells and incubated for a further
72 h. Enrichment of primary or cell line–derived mature MKs was by ve-
locity sedimentation through a discontinuous 1.5%, 3.0% BSA gradient at
1 g, collecting those cells reaching the bottom within 30 min. Purified pri-
mary MKs were replated and cultured with 30 ng/ml
 TPO and 10% normal
human plasma. MKs were treated with the following reagents: 100 or 10
 M zVAD-fmk (Bachem), 10  M zDEVD-fmk, 10  M zIETD-fmk (Calbio-
chem); 50 ng/ml
 anti-Fas agonistic antibody CH.11 (Upstate Biotechnol-
ogy), 1  g/ml
 anti-Fas antagonistic antibody ZB4 (Upstate Biotechnology),
5 ng/ml
 soluble Fas ligand and enhancer (Qbiogene), 25 ng/ml
 TNF- 
(R&D Systems), and 250 ng/ml
 JO-2 (BD Biosciences). Phagocytic assaysT
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with MDMs were as described previously (Brown et al., 2000). Direct pro-
tein transfection was achieved using BioPORTER
® II (Gene Therapy Sys-
tems) as instructed. In brief, CrmA (Kamiya Biomedical) or caspase-8
(CHEMICON International) in PBS was complexed with the BioPORTER
®
reagent for 5 min before the addition of cells in serum-free media. After 3 h
of incubation, an equal volume of 20% serum media was applied, and
cells were cultured for a further 8 h before enumeration of proplatelet-
bearing MKs.
Ex vivo bone culture
Trabecular bone from femoral heads was isolated from a 58-yr old male
patient undergoing hip surgery, machined with high precision to cylindri-
cal cores under sterile conditions, and inserted into the loading chambers
of a Zetos™ bone perfusion system (Smith and Jones, 1998; EOBM, Phil-
ipps-University, Marburg, Germany). Each core was maintained at 37 C /
5% CO2 and perfused with 5 ml DME, recirculated at a rate of 5 ml/h. On
day 5, the circulating media was replaced with 5 ml of fresh media con-
taining 50 ng/ml
 Fas agonistic antibody CH.11 and/or 100  M zVAD-fmk.
The fresh media was then perfused and recirculated for 18 h at 5 ml/h be-
fore the eluent was collected and the bone core flushed with 5 ml of PBS.
Large cellular material was removed by centrifugation (200 g for 5 min)
and remaining supernatant components concentrated by centrifugation
(1,500 g for 15 min). Resuspended pellets were stained for GpIIb (Serotec)
and GpIIIa (CALTAG Laboratories), and analyzed on a FACScan™ (Becton
Dickinson), with reference to a fixed count of 10- m beads (Polysciences,
Inc.) for platelet enumeration.
Flow cytometry
Culture supernatants containing platelets were separated by centrifugation
at 300 g for 2 min, and platelets were enumerated by reference to a fixed
count of 10- m polystyrene beads (Polysciences, Inc.). Functional plate-
lets were distinguished from cellular debris by a characteristic increase in
side scatter on shape change after 0.5 U/ml
 thrombin or 3  M ADP treat-
ment, and an absence of 0.3  l/ml
 annexin-V binding (Boehringer) to the
shape changed population (Otterdal et al., 2001). All conditions contained
10  g/ml
 propidium iodide as a dead cell gate. Transient calcium flux was
detected using 10  m Fluo3-AM (Molecular Probes, Inc.). Agonist-induced
activation of the fibrinogen receptor (GpIIb/IIIa) by 3 U/ml
 thrombin was
assessed by increased binding of 2.5  g/ml
 Fibrinogen-Alexa Fluor (Molec-
ular Probes, Inc.). Samples were analyzed on a FACScalibur™ system
(Becton Dickinson) using CellQuest software. Immunofluorescent labeling
of intact platelets for   M was performed by adding 5  l of platelets to
400  l of PBS w/o Ca
2  containing 10  g/ml
 JC-1 (Molecular Probes, Inc.),
followed by incubation for 20 min at 37 C, before sampling by flow cy-
tometry. Deliberate uncoupling of the respiratory chain with loss of plate-
let   M was achieved by direct addition of 10  g/ml
 of the protonophore
mCCCP.
Microscopy
Images were captured on an inverted microscope (Axiovert S100; Carl
Zeiss MicroImaging, Inc.) equipped with a CoolSNAP CCD camera and
OpenLab 3.0 image analysis software (ImproVision). Confocal images
were captured on a confocal microscope and software system (TCS NT;
Leica). Active caspases were detected using CaspaTag™ (Serologicals) as
instructed.    M was qualitatively determined using JC-1 (Molecular
Probes, Inc.) at a final concentration of 5  g/ml. Nuclear morphology
was detected using 2  g/ml
 Hoechst 33342. For TEM cells or culture su-
pernatants were fixed with excess 2.5% glutaraldehyde in 0.1 M sodium
cacodylate buffer (EM grade I), followed by embedding within a fibrin
plug as described previously (Brown et al., 2000). Plugs were subse-
quently treated as normal resected tissue and processed with osmium
tetroxide, lead citrate, and araldite embedding, followed by 80-nm ultra
thin sectioning. Samples were analyzed on an electron microscope
(CM12; Philips).
Platelet isolation and culture
Freshly drawn venous blood was obtained from aspirin-free healthy do-
nors, citrated (0.33%; Pharma Hameln), and PRP was prepared by centrif-
ugation (350 g, 20 min). Washed platelets were prepared by diluting PRP
with 5 vol of HBSS, pH 6.4, containing EDTA (4 mM final) into a round-
bottom capped polystyrene centrifuge tube before centrifugation (280 g for
20 min). After washing, platelets were resuspended in HBSS, pH 6.4, and
maintained at 37 C in a closed (capped) tube at 3   10
8 ml. Low levels of
contaminating leukocytes were removed from platelet preparations after
two successive rounds of centrifugation (220 g for 5 min) in which the su-
pernatant was retained each time.
Cell free apoptosis and cytochrome c immunoprecipitation
Jurkat T cell and platelet lysates were prepared by resuspending cells in ly-
sis buffer (20 mM Hepes, pH 7.5, 10 mM KCl, 1.5 mM MgCl, 1mM EDTA,
1 mM EGTA, 1 mM DTT, 100  m PMSF, 10  g/ml leupeptin, and 2  g/ml
aprotinin) and were incubating for 10 min on ice. Platelets were subjected
to three cycles of freeze-thaw. Cells were further disrupted by passing
through a 25 G needle 10 times. Cell free apoptosis was initiated by addi-
tion of 10  g/ml
 cytochrome c and 1 mM dATP, and in some experiments,
0.1 U/ml
 human recombinant caspase-9 (CHEMICON International), fol-
lowed by incubation at 37 C. At time points indicated aliquots were
removed and directly added to x4 SDS Laemmli sample buffer, and im-
mediately boiled for 3 min. For cytochrome c, washed platelets were
resuspended in ice-cold 10 mM Hepes buffer (containing 1 mM EDTA, 1
mM 1,10-phenanthroline, 1 mM PMSF, 1 mM benzamidine, 10  M pep-
statin, 10  M leupeptin, and 10  M antipain, pH 8.0) and lysed after two
rounds of freeze-thaw. The lysed platelets were centrifuged (13,000 g for
10 min) to yield a cytosolic supernatant, whereas the pellet was resus-
pended in lysis buffer before centrifuging again and dissolving the pellet in
1% TX-100 to release mitochondrial cytochrome c. The soluble fractions
were then precleared with a control IgG and Protein G agarose before im-
munoprecipitating cytochrome c with clone 6H2.B4 (BD Biosciences) and
boiling in SDS sample buffer. Cycloheximide (20  g/ml)-treated Jurkats
were used as a positive control and prepared identically.
SDS-PAGE and immunoblotting
SDS-PAGE and immunodetection of transblotted protein to PVDF mem-
branes was performed as described previously (Brown et al., 1997). West-
ern blots were probed with anti-caspase-3 pAb, anti-caspase-9 pAb and
mAb (clone B40), anti-APAF-1 pAb, and anti-cytochrome c mAb (clone
7H8.2C12), all purchased from BD Biosciences. Molecular weight markers
used were Rainbow markers, SDS-7B, or BenchMark (GIBCO BRL).
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